Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early clozapine intensification versus treatment as usual after first antipsychotic failure in schizophrenia-spectrum disorders
ISRCTN83479057Phase 4Recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Aug 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 4, randomised, open-label trial of clozapine in schizophrenia, schizoaffective disorder and schizophreniform disorder (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Change in symptom severity. Started Aug 2023; status: recruiting.
02
Drugs
clozapine
03
Conditions
schizophreniaschizoaffective disorderschizophreniform disorder
Beyond the preview
Go deeper on ISRCTN83479057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN83479057.